Delivery Order SPE2DR25D9144-SPE2DR26FDKF6
Award Date 5/11/26
Potential Completion Date 6/2/26
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 31, 2026, for NUPLAZID 34 mg capsule 30s with a ceiling value of $3,923.82. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations. Place of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for NUPLAZID 34 mg capsule 30s with a ceiling value of $3,923.82. The order was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- <p>The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 21, 2026, with a ceiling value of $3,923.82 for NUPLAZID 34 mg capsule 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>Place of performance is Park Ridge, Illinois. The ultimate completion date is May 12, 2026. The order is priced firm fixed-price with no set-aside designation.</p>
- The Defense Logistics Agency issued a $11,771.46 delivery order to DMS Pharmaceutical Group Inc. on May 4, 2026, for NUPLAZID 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling through December 31, 2036, authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to Department of Defense military...
- The Defense Logistics Agency issued a $3,923.82 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 17, 2026, for NUPLAZID 34 mg capsule (30-count) supply under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for branded and generic prescription drugs, biologics, over-the-counter medications, vaccines, and medical consumables supporting Department...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 20, 2026, for NUPLAZID 34 mg capsule 30-count units with a ceiling value of $3,923.82 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of May 11, 2026. This delivery order is issued under the Defense...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on January 21, 2026, with a ceiling value of $11,771.46 for Nuplazid 34 mg capsules (30-count). The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a firm fixed-price indefinite delivery contract awarded to DMS Pharmaceutical Group on November 13, 2025, with a $499.999 billion ceiling and ultimate...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, for Nuplazid 34 mg capsule 30-count units with a ceiling value of $11,771.46 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the single-award indefinite delivery contract SPE2DX, a $499.999 billion vehicle awarded by the Defense Logistics Agency on November 13, 2025,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, for $11,771.46 ceiling value under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Nuplazid 34 mg capsules. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under PPV-G GEN V, the Defense Logistics Agency's single-award indefinite delivery contract (SPE2DX) for pharmaceutical and medical consumable supply to...
- The Defense Logistics Agency issued a $3,925.34 delivery order to DMS Pharmaceutical Group Inc. on April 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for NUPLAZID 10 mg tablets (30-count). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The order is firm fixed price with an ultimate completion date of April 23, 2026. Place of...